TALPHERA, INC. Inventory Write-down
TALPHERA, INC. (TLPH) reported Inventory Write-down of $0 for the 12-month period ending 2022-12-31, per its 8-K filed 2023-08-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2023-08-01
- TALPHERA, INC. inventory write-down for the quarter ending 2020-12-31 was $112.00K, a 22.76% decline year-over-year.
- TALPHERA, INC. inventory write-down for the quarter ending 2020-09-30 was $200.00K, a 77.78% decline year-over-year.
- TALPHERA, INC. inventory write-down for the quarter ending 2020-06-30 was $300.00K.
- TALPHERA, INC. inventory write-down for the quarter ending 2020-03-31 was $100.00K.
- TALPHERA, INC. inventory write-down for fiscal 2020 was $712.00K, a 28.80% decline from fiscal 2019.
- TALPHERA, INC. inventory write-down for fiscal 2019 was $1.00M.
- TALPHERA, INC. inventory write-down for fiscal 2017 was $369.00K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month | Inventory Write-down 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 8-K · filed 2023-08-01 | ||||
| 2021-12-31 | $810.00K 8-K · filed 2023-08-01 | ||||
| 2020-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $312.00K derived: sum of 2 quarters · filed 2022-03-10 | $612.00K derived: sum of 3 quarters · filed 2022-03-10 | $712.00K 10-K · filed 2022-03-10 | $700.00K 10-K · filed 2021-03-15 |
| 2020-09-30 | $200.00K 10-Q · filed 2020-11-05 | $500.00K derived: sum of 2 quarters · filed 2020-11-05 | $600.00K 10-Q · filed 2020-11-05 | $745.00K derived: sum of 4 quarters · filed 2021-03-15 | |
| 2020-06-30 | $300.00K 10-Q · filed 2020-08-10 | $400.00K 10-Q · filed 2020-08-10 | $545.00K derived: sum of 3 quarters · filed 2021-03-15 | $1.45M derived: sum of 4 quarters · filed 2021-03-15 | |
| 2020-03-31 | $100.00K 10-Q · filed 2020-05-11 | $245.00K derived: sum of 2 quarters · filed 2021-03-15 | $1.15M derived: sum of 3 quarters · filed 2021-03-15 | ||
| 2019-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $1.04M derived: sum of 2 quarters · filed 2021-03-15 | $1.00M 10-K · filed 2021-03-15 | $951.00K 10-K · filed 2020-03-16 | |
| 2019-09-30 | $900.00K 10-Q · filed 2019-11-07 | $855.00K 10-Q · filed 2019-11-07 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | $369.00K 10-K · filed 2020-03-16 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $369.00K 10-Q · filed 2018-11-05 | |||
| 2017-06-30 | $369.00K 10-Q · filed 2018-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |